Table 2

Previously reported circulating microRNA (miRNA) for the diagnosis of OAC and/or BO

AuthorsCasesControlsCombination of miRNAAUCSen.Spe.
Bus et al 30 OAC
(n=59)
Healthy
(n=15)
miR-133a-3p, miR-382-5 p, miR-451a0.850.860.8
Bus et al 30 BO
(n=41)
Healthy
(n=15)
miR-133a-3p, miR-136-5 p, miR-382-5 p0.80.810.78
Chiam et al 58 OAC
(n=18)
Healthy
(n=19)
RNU6-1, miR-16-5 p, miR-25-3 p, miR-320a, let-7e-5p, miR-15b-5p, miR-30a-5p, miR-324-5 p, miR-17-5 p, miR-194-5 p0.99NDND
Zhai et al 59 OAC
(n=30)
Healthy
(n=30)
miR-187, miR-1912, miR-3692, miR-3679-5 p, miR-1273d, miR-625, miR-200b, miR-4290, miR-591, miR-125a-3p, miR-3147, miR-4267, miR-640, miR-3652, miR-551b, miR-4323, miR-3714, miR-593NDNDND
Zhang et al 60 OAC
(n=10)
Healthy
(n=11)
miR-25-3 p, miR-151a-3p, miR-100-5 p, miR-375NDNDND
Cabibi et al 52 BO
(n=8)
Oesophagitis
(n=10)
miR-143, miR-145, miR-194, miR-215, miR-2-4, miR-205NDNDND
  • AUC, area under the receiver operating characteristic curve; BO, Barrett’s oesophagus; ND, not described; OAC, oesophageal adenocarcinoma; Sen., sensitivity; Spe., specificity.